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Abstract  
Medicinal plants have been a valuable source of natural active phytoconsituents that play an important role in 
treatment of many human diseases. In the present study, stem (St), leaf (Lf), root (Rt), and fruit (Ft) of Ficus 
hispida L. was evaluated for its antibacterial potential. The Soxhlet extraction was done by using three different 
solvents viz., acetone, methanol and water. The antimicrobial activity was evaluated by an agar disc diffusion 
method against four bacterial strains viz., Staphylococcus aureus (NCIM 5345), Escherichia coli (NCIM 2931), 
Enterobacter aerogenes (NCIM 5139), Pseudomonas aeruginosa (NCIM 5029) and two fungal strains viz., 
Fusarium proliferatum (NCIM 1103), Fusarium oxysporum (NCIM 1281).The methanol extracts showed better 
antimicrobial activity than acetone and aqueous extracts. This may be because of the difference in the presence 
of phytoconsituents present in them.  
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Introduction 
The potential of higher plants as source for new drugs is still largely unexplored. Among the estimated 250,000-
500,000 plant species, only a small percentage has been investigated phytochemically and the fraction submitted 
to biological or pharmacological screening is even smaller. Historically pharmacological screening of 
compounds of natural or synthetic origin has been the source of innumerable therapeutic agents. Random 
screening as tool in discovering new biologically active molecules has been most productive in the area of 
antibiotics (Gerhartz, et al.1985 and Kroschwitz et al.,1992). Even now, contrary to common belief, drugs from 
higher plants continue to occupy an important 130 drugs, all single chemical entities extracted from higher plants, 
or modified further synthetically, are currently in use, though some of them are now being made synthetically for 
economic reasons (Newman et al., 2000). India is a varietal emporium of medicinal plants and is one of the 
richest countries in the world as regards to genetic resources of medicinal plants. All known types of agro 
climatic, ecological and edaphic conditions are met within India. The biogeographic position of India is unique 
which makes India rich in all the three levels of biodiversity (Krishnaraju et al., 2006). Some studies focusing on 
the investigation of traditional Indian medicinal plants have resulted in the identification of new sources of 
therapeutic agents (Ahmad et al., 2001).  
Medicinal plants represent a rich source of antimicrobial agents. Plants are used medicinally in different 
countries and are a source of many potent and powerful drugs (Srivastava et al., 1996). A wide range of 
medicinal plant parts is used for extract as raw drugs and they possess varied medicinal properties. The different 
parts used include root, stem, flower, fruit, twigs exudates and modified plant organs. While some of these raw 
drugs are collected in smaller quantities by the local communities and folk healers for local used, many other raw 
drugs are collected in larger quantities and traded in the market as the raw material for many herbal industries 
(Uniyal et al., 2006). Although hundreds of plant species have been tested for antimicrobial properties, the vast 
majority of have not been adequately evaluated (Balandrin et al., 1985). 
Plants are recognized for their ability to produce a wealth of secondary metabolites and mankind has 
used many species for centuries to treat a variety of diseases. The curative properties of herbs lie in secondary 
metabolites with in situ functions including growth regulation, inter and intra-specific interactions and defense 
against predators and infections. Many of these natural products have been shown to present interesting 
biological and pharmacological activities and are used as chemotherapeutic agents or serve as the starting point 
in the development of modern medicines (Verpoorte et al., 1998, 2000).  Herbs are safe, less toxic, economical 
and a reliable key natural resource of drugs all over the world (Cragg et al., 1999). Many infectious diseases 
have been known to be treated with herbal remedies throughout the history of mankind. In addition, in 
developing countries, synthetic drugs are not only expensive and inadequate for the treatment of disease, but are 
also faced with adulteration and side effects. Therefore, there is a need to search new safe infection fighting 
strategies to control microbial infection.  Natural products, either as pure compounds or as standardized plant 
extracts, provide unlimited opportunities for new drug leads because of the unmatched availability of chemical 
diversity. There is a continuous and an urgent need to discover new antimicrobial compounds with diverse 
chemical structures and novel mechanisms of action for new and re-emerging infectious diseases (Rojas et al., 
2003). Therefore, researchers are increasingly turning their attention to folk medicine, looking for new leads to 
develop better drugs against microbial infections. The increasing failure of chemotherapeutics and antibiotic 
resistance exhibited by pathogenic microbial infectious agents has led to the screening of several medicinal 
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plants for their potential antimicrobial activity. Thus, plants can be investigated for their antimicrobial efficacy.  
 
Material and Method 
Several seasonal surveys will be made to collect the plant material for the experimentation.  
 
Collection of Plant Materials: 
Collection will be carried out from forest localities from Yavatmal district. Identification will be made with the 
help of standard floras (Karthikeyan and Kumar, 1993, Kamble and Pradhan, 1988, Naik, 1998 and Singh et al., 
2001). 
 
Preparation of Powder and Extract of Various Parts of Selected Plant : 
The collected plant material will be shade dried and mechanically powdered and stored in an airtight container. 
Various extracts will be prepared according to the methodology of Sadashivan and Manickam (2005), will be 
subjected to our entire studies. The shade dried plants parts will be allowed to pulverization to get coarse powder. 
The coarse powder material will be subjected to Soxhlet extraction separately and successively with acetone, 
methanol and aqueous extracts. These extracts will be concentrated to dryness in flash evaporator. 
 
Antimicrobial Activity: 
Antimicrobial activity will be carried by using antibiotic sensitivity Agar (Hi-Media) by disc diffusion method 
(Elizabeth, 2005) against four bacterial strains viz., Staphylococcus aureus (NCIM 5345), Escherichia coli 
(NCIM 2931), Enterobacter aerogenes (NCIM 5139), Pseudomonas aeruginosa (NCIM 5029) and two fungal 
strains viz., Fusarium proliferatum (NCIM 1103), Fusarium oxysporum (NCIM 1281). 
 
Results And Discussion:  
Antimicrobial activity methanol, acetone and aqueous extract of all part of plant extracts was tested with four 
bacterial strain- E. aerogenes, P. aerogenosa, E. Coli, S. aurius and two fungal strain- F. oxysporum and F. 
proliferatum (table no.1).  Methanol extract shows better antimicrobial activity than acetone and aqueous extract. 
Methanol extract of stem and root shows higher zone of inhibition for F.oxysporum than other microbes, 
methanol extract of leaf and fruit shows higher zone of inhibition for E. aerogenes . Aqueous extract of stem  a 
shows higher zone of inhibition for P. aerogenosa than other microbes, aqueous  extract of leaf and fruit a shows 
higher zone of inhibition for F. oxysporum than other microbes. Acetone extract of stem and fruit shows higher 
zone of inhibition for F. proliferatum than other microbes, acetone extract of leaf shows higher zone of 
inhibition for E. aerogenes and  F. oxysporum than other microbes, acetone extract of root shows higher zone of 
inhibition for P. aerogenosa and  F. proliferatum than other microbes (Fig 1.1,1.2,1.3,1.4). This is because of the 
difference in the presence of phytoconsituents present in them.  
Table 1 : Antimicrobial activity of Ficus hispida  extracts. 
 
Sr.No. 
 
Name of microorganisms 
 
Extracts 
Diameter of zone of inhibition in mm 
St Lf Rt Ft 
1 E. aerogenes Aq 6 6 10 11 
Ac 10 13 6 12 
Me 6 15 10 15 
2 P. aerogenosa Aq 9 6 10 8 
Ac 10 11 12 11 
Me 13 14 12 13 
3 E. Coli Aq 7 10 6 6 
Ac 11 12 6 6 
Me 11 14 6 12 
4 S. aurius Aq 7 6 8 11 
Ac 10 10 11 12 
Me 10 11 11 13 
5 F. oxysporum Aq 6 12 10 12 
Ac 12 13 11 13 
Me 15 14 16 14 
6 F. proliferatum Aq 6 8 10 11 
Ac 14 10 12 14 
Me 14 12 15 14 
Note : St - Stem , Lf – Leaf , Rt – Root , Ft – Fruit , Aq – Aqueous , Ac – Acetone ,  
          Me – Methanol 
Journal of Natural Sciences Research                                                                                                                                                www.iiste.org 
ISSN 2224-3186 (Paper)   ISSN 2225-0921 (Online) 
Vol.6, No.7, 2016 
 
69 
Fig. 1.1: Antimicrobial activity of stem extract of F. hispida 
 
 
Fig. 1.2: Antimicrobial activity of leaf extract of F. hispida 
 
 
Fig. 1.3: Antimicrobial activity of root extract of F. hispida 
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Fig. 1.4: Antimicrobial activity of fruit extract of F. hispida 
 
 
Conclusion   
The results of present investigation clearly indicate that, the plant rich in secondary metabolite.  They show 
antibacterial and antifungal activity for selected strains. Thus the plants under investigation showed their 
medicinal potential and can be a source of useful drugs. More phytochemical research work is required for 
isolation, purification and characterization of biologically active compounds. Since the plant, Ficus hispida is 
useful in traditional medicine for the treatment of various ailments; it is need of time to standardize the plant for 
development of quality control parameters.  
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